| scholarly article | Q13442814 |
| P50 | author | Bruno Pozzetto | Q64763423 |
| Didier Raoult | Q915676 | ||
| P2093 | author name string | F Morfin | |
| H Fleury | |||
| M E Lafon | |||
| J M Seigneurin | |||
| B Picard | |||
| P Morand | |||
| C Scieux | |||
| C Zandotti | |||
| S Omar | |||
| F Morinet | |||
| M Segondy | |||
| J Puel | |||
| C Henquell | |||
| C Mengelle | |||
| T Hadou | |||
| L Finkielsztejn | |||
| A Le Faou | |||
| B Chanzy | |||
| G Agius | |||
| M Aymard | |||
| M C Legrand | |||
| S Billaudel | |||
| D Thouvenot | |||
| H Lafeuille | |||
| R Teyssou | |||
| E Nicand | |||
| M Coste-Burel | |||
| C Danve-Szatanek | |||
| I Bertin | |||
| L Maille | |||
| P2860 | cites work | A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS | Q76986488 |
| Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition | Q33646854 | ||
| AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study | Q33884269 | ||
| Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis | Q34113403 | ||
| European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). | Q34734136 | ||
| The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes | Q35528404 | ||
| Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus | Q35542095 | ||
| Survey of resistance of herpes simplex virus to acyclovir in northwest England | Q39557442 | ||
| Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis | Q39652814 | ||
| Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. | Q39785429 | ||
| In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme. | Q40117537 | ||
| Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus | Q40706720 | ||
| Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients | Q41017843 | ||
| A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs | Q43494754 | ||
| Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation | Q43738088 | ||
| Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child | Q43816539 | ||
| A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir | Q44149207 | ||
| Occurrence and characterization of acyclovir‐resistant herpes simplex virus isolates: Report on a two—year sensitivity screening survey | Q44354849 | ||
| A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents | Q44374165 | ||
| The role of herpes simplex virus type 1 thymidine kinase in pathogenesis | Q44549973 | ||
| Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey | Q44644683 | ||
| Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome | Q45281990 | ||
| Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant | Q45739692 | ||
| Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation | Q45740042 | ||
| Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance | Q45742120 | ||
| Susceptibility of clinical strains of herpes simplex virus to three nucleoside analogues | Q45743153 | ||
| Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population | Q45753625 | ||
| Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus | Q45757579 | ||
| Foscarnet therapy for acyclovir-resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients | Q45769103 | ||
| Foscarnet-resistant herpes simplex virus infection in patients with AIDS. | Q45777032 | ||
| Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child | Q45799596 | ||
| Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir | Q45800896 | ||
| Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy | Q45806441 | ||
| Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide | Q45837075 | ||
| Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. | Q45846461 | ||
| Herpes simplex virus resistant to acyclovir. A study in a tertiary care center | Q45851795 | ||
| Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient. | Q54186775 | ||
| Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. | Q54223788 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 242-249 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up | |
| P478 | volume | 42 |
| Q37685326 | Acute Liver Failure from Herpes Simplex Virus in an Immunocompetent Patient Due to Direct Inoculation of the Peritoneum |
| Q42280324 | Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. |
| Q33815823 | Acyclovir resistance in herpes simplex virus type I encephalitis: a case report |
| Q36688958 | Advances in the antiviral therapy of herpes virus infection in children. |
| Q30350341 | Agents and strategies in development for improved management of herpes simplex virus infection and disease. |
| Q57171792 | Antiviral Therapies for Herpesviruses: Current Agents and New Directions |
| Q38194111 | Antiviral drug resistance in herpesviruses other than cytomegalovirus |
| Q28282376 | Antiviral drug resistance: mechanisms and clinical implications |
| Q24635330 | Antiviral drugs for viruses other than human immunodeficiency virus |
| Q40222954 | Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients |
| Q36729580 | Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection |
| Q36555158 | Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. |
| Q37060583 | Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection |
| Q38598512 | Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2. |
| Q36207868 | Dendritic cells in viral pathogenesis: protective or defective? |
| Q36463219 | Diagnostics for herpes simplex virus: is PCR the new gold standard? |
| Q40553715 | ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing |
| Q41218432 | Effect of dimeric netropsin analogue 15Lys-bis-Nt and acyclovir on the reproduction of herpes simplex virus type 1. The search for variants of herpes virus with drug resistance to 15Lys-bis-Nt and acyclovir. |
| Q36882562 | Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures |
| Q36735386 | Evaluation of cytotoxic potential of newly synthesized antiviral aminopyrazoloquinoline derivatives |
| Q35105400 | Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles |
| Q34569223 | Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman. |
| Q36898071 | Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D. |
| Q34290117 | Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. |
| Q36866689 | Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics |
| Q38351481 | Helicase-primase as a target of new therapies for herpes simplex virus infections. |
| Q28067618 | Herpes Genitalis: Diagnosis, Treatment and Prevention |
| Q26853504 | Herpes simplex epithelial and stromal keratitis: an epidemiologic update |
| Q39693154 | Herpes simplex virus (HSV) immediate-early (IE) promoter-directed reporter system for the screening of antiherpetics targeting the early stage of HSV infection |
| Q38248209 | Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease. |
| Q42272329 | Herpes simplex virus in solid organ transplantation |
| Q42169617 | Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study |
| Q40590036 | Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes. |
| Q34035099 | Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy |
| Q35076909 | Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread |
| Q56789970 | In search for effective and definitive treatment of herpes simplex virus type 1 (HSV-1) infections |
| Q36777844 | Interactions and management issues in HSV and HIV coinfection |
| Q42227993 | Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection |
| Q36851163 | Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation Associated With Resistance. |
| Q34578009 | Management of recurrent oral herpes simplex infections. |
| Q36520832 | Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections |
| Q36236198 | Net -1 frameshifting on a noncanonical sequence in a herpes simplex virus drug-resistant mutant is stimulated by nonstop mRNA. |
| Q26746041 | Optimal management of genital herpes: current perspectives |
| Q36478736 | Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. |
| Q45402381 | Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection |
| Q36799211 | Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody |
| Q39609010 | Oxoquinoline derivatives: identification and structure-activity relationship (SAR) analysis of new anti-HSV-1 agents. |
| Q39627411 | Pentagalloylglucose downregulates cofilin1 and inhibits HSV-1 infection |
| Q57065815 | Photodynamic Inactivation of Herpes Simplex Viruses |
| Q36015799 | Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients. |
| Q98226277 | Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine |
| Q35868002 | Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells |
| Q34354018 | Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitis |
| Q37101332 | Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for aciclovir susceptibility |
| Q35923346 | Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients |
| Q34149904 | Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management |
| Q34479800 | Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance |
| Q40377171 | Study of Antiherpetic Efficiency of Phosphite of Acycloguanosine Ableto Over come the Barrier of Resistance to Acyclovir |
| Q45361068 | Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1. |
| Q37628669 | Testing the susceptibility of human herpesviruses to antivirals |
| Q44567148 | The in vitro anti-herpes simplex virus type-1 and type-2 activity of Long Dan Xie Gan Tan, a prescription of traditional Chinese medicine |
| Q21296712 | Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown |
| Q38950995 | UL52 primase interactions in the herpes simplex virus 1 helicase-primase are affected by antiviral compounds and mutations causing drug resistance |
| Q34190321 | Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials |
| Q42277082 | Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients |
| Q51594265 | Viral infection in renal transplant recipients. |
| Q57235754 | Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients |
| Q82543515 | [Herpes simplex prophylaxis in facial exfoliation treatments] |
Search more.